Changeflow GovPing Healthcare & Life Sciences Neonatal incubator safety alert: Lifetherm 2000
Priority review Notice Removed Final

Neonatal incubator safety alert: Lifetherm 2000

Favicon for ansm.sante.fr ANSM Drug & Device Safety Alerts
Published
Detected
Email

Summary

The ANSM has issued a safety alert regarding the Lifetherm 2000 neonatal incubator manufactured by Löwenstein Medical GmbH & Co. KG. The alert, registered under number R2607231, concerns a specific healthcare facility and includes a letter from the manufacturer detailing the safety action.

Published by ANSM on ansm.sante.fr . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The French National Agency for Medicines and Health Products Safety (ANSM) has issued a safety alert (R2607231) concerning the Lifetherm 2000 neonatal incubator, manufactured by Löwenstein Medical GmbH & Co. KG. This alert specifically targets a single healthcare facility and is accompanied by a letter from the manufacturer detailing the safety action being implemented. The document indicates a recall or corrective action is underway for this medical device.

Healthcare providers using the Lifetherm 2000 incubator should review the manufacturer's letter and follow any instructions provided to ensure patient safety. Compliance officers should verify if their facility is the one identified and ensure all recommended actions are taken promptly. Further details on the specific safety issue and required actions are contained within the linked manufacturer's letter.

What to do next

  1. Review manufacturer's safety action letter for Lifetherm 2000 incubators
  2. Implement any recommended corrective actions or procedures

Archived snapshot

Mar 16, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

A+ A-

Information n° R2607231 destinée aux pharmacies d'usage intérieur Cette action de sécurité est enregistrée à l’ANSM sous le n° R2607231. Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité.

L'ANSM a été informée de la mise en œuvre d’une action de sécurité effectuée par la société Löwenstein Medical GmbH & Co. KG.

L’unique établissement de santé concerné a reçu le courrier ci-joint. Téléchargez le courrier de la société Löwenstein Medical GmbH & Co. KG. (16/03/2026)

Get daily alerts for ANSM Drug & Device Safety Alerts

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from ANSM.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
ANSM
Published
March 16th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Healthcare providers
Geographic scope
France France

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Product Safety Medical Devices

Get alerts for this source

We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!